Literature DB >> 25386430

Antibiotic resistance in uropathogenic e. Coli strains isolated from non-hospitalized patients in pakistan.

Ihsan Ali1, Neeraj Kumar2, Safia Ahmed3, Javid Iqbal Dasti4.   

Abstract

PURPOSE: To study multidrug-resistance in Uropathogenic E. Coli (UPEC) isolated from non-hospitalized patients.
MATERIALS AND METHODS: Altogether, 250 bacterial samples were collected from non-hospitalized patients. Their identifications were done on basis of Gram-staining, colony morphology, biochemical testing and PCR. Susceptibility testing was performed by using standard protocols which were recommended by CLSI. STATISTICAL ANALYSIS: For comparisons, statistical analysis was performed by using software, Graphpad Prism 5.0
RESULTS: In total, 32% (n = 80) of the isolates were identified as E. Coli strains and their susceptibility patterns for different antibiotics were determined. The data indicated least resistance against tazocin [(TZP) -1.25%], amikacin [(AK) -1.8%], tigecycline [(TGC)- 2.5%] and nitrofurantoin [(F) -3.75%]. For both minocycline (MH) and sulzone (SUL), resistance rate was 5%, for gentamicin (CN), it was 16.25%, while higher resistances were observed against cephalothine [(KF)- 70%], cefotaxime [(CTX) -58.5%], ceftazidime [(CAZ)- 57.5%], cefepime [(FEP) -55%], cefuroxime and cefixime [(CXM) (CFM)- 53.75 %]. Resistance against ciprofloxacin (CIP) was 57.5%, for norfloxacine (NOR), it was 52.5% and incase of sparfloxacin (SPX), it remained 55%. High percentage of the isolates were resistant to cotrimoxazole [(SXT) -86%] and Amoxicillin [AMX-CLA (AMC)- 76%]. No resistance against meropenem (MEM) was observed.
CONCLUSION: Highest level of drug-resistance was observed against trimethoprim-sulfamethoxazole (TMP-SMZ) among clinical isolates of uropathogenic E. Coli collected from non-hospitalized patients.

Entities:  

Keywords:  Antibiotic susceptibility; Beta-lactamase; Cotrimoxazole; E. Coli; Plasmids; UPEC

Year:  2014        PMID: 25386430      PMCID: PMC4225882          DOI: 10.7860/JCDR/2014/7881.4813

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  20 in total

Review 1.  Penetration of antimicrobial agents into the prostate.

Authors:  Konstantin Charalabopoulos; George Karachalios; Dimitrios Baltogiannis; Alexander Charalabopoulos; Xenofon Giannakopoulos; Nikolaos Sofikitis
Journal:  Chemotherapy       Date:  2003-12       Impact factor: 2.544

2.  Extremely rapid extraction of DNA from bacteria and yeasts.

Authors:  Hai-Rong Cheng; Ning Jiang
Journal:  Biotechnol Lett       Date:  2006-01       Impact factor: 2.461

3.  Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.

Authors:  James A Karlowsky; Daryl J Hoban; Melanie R Decorby; Nancy M Laing; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 4.  Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.

Authors:  K Gupta; T M Hooton; W E Stamm
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

5.  Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

Authors:  D F Sahm; C Thornsberry; D C Mayfield; M E Jones; J A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 6.  An update on the role of nitrofurans in the management of urinary tract infections.

Authors:  D R Guay
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Urinary tract infection in adults: research priorities and strategies.

Authors:  A R Ronald; L E Nicolle; E Stamm; J Krieger; J Warren; A Schaeffer; K G Naber; T M Hooton; J Johnson; S Chambers; V Andriole
Journal:  Int J Antimicrob Agents       Date:  2001-04       Impact factor: 5.283

Review 8.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

9.  Fluoroquinolone prescribing in the United States: 1995 to 2002.

Authors:  Jeffrey A Linder; Elbert S Huang; Michael A Steinman; Ralph Gonzales; Randall S Stafford
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

Review 10.  Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.

Authors:  Karen Bush
Journal:  Crit Care       Date:  2010-06-29       Impact factor: 9.097

View more
  4 in total

1.  Study of class 1 integrons in multidrug-resistant uropathogenic Escherichia coli isolated from different hospitals in Karachi.

Authors:  Fouzia Zeeshan Khan; Tehseen Nawaz; Zulfiqar Ali Mirani; Saeed Khan; Yasir Raza; Shahana Urooj Kazmi
Journal:  Iran J Basic Med Sci       Date:  2018-10       Impact factor: 2.699

2.  Antibiotic resistance in Pakistan: a systematic review of past decade.

Authors:  Hazrat Bilal; Muhammad Nadeem Khan; Tayyab Rehman; Muhammad Fazal Hameed; Xingyuan Yang
Journal:  BMC Infect Dis       Date:  2021-03-06       Impact factor: 3.090

3.  Twelve-year trend of Escherichia coli antibiotic resistance in the Islamabad population.

Authors:  Kashif Bangash; Hassan Mumtaz; Mehwish Mehmood; Majid Ali Hingoro; Zoobia Z Khan; Ahmed Sohail; Sami Ullah; Durishahwar Maqbool; Neelum Jamal; Momina Sami Khan; Shahzaib Ahmad; Anum Sohail; Hassan Ul Hussain; Irfan Ullah
Journal:  Ann Med Surg (Lond)       Date:  2022-05-27

4.  An Investigation into the Quality of Medicines in Yangon, Myanmar.

Authors:  Md Rafiqul Islam; Naoko Yoshida; Kazuko Kimura; Chisana Uwatoko; Mohammad Sofiqur Rahman; Shoma Kumada; Jamie Endo; Kana Ito; Tsuyoshi Tanimoto; Theingi Zin; Hirohito Tsuboi
Journal:  Pharmacy (Basel)       Date:  2018-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.